Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
$76.94
$1.79 (+2.39%)
$74.91Day Range$77.00
Key Statistics
Market Cap
$5.86B
Shares Outstanding
78.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 24, 2018
Round Lot
100
Locale
US
Trading Data
Day Open
$75.06
Day High
$77.00
Day Low
$74.91
Volume
185.6K
VWAP
$76.49
Prev Close
$75.15
Transactions
--
Acc. Volume
--
About Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
PHARMACEUTICAL PREPARATIONSSIC 2834366 employees105 PICCADILLY, SECOND FLOOR, LONDON, W1J 7NJ(781) 431-9100IPO May 24, 2018US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001730430
- Ticker Root
- KNSA
- SIC Code
- 2834
About Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) Stock
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) closed the 2026-09-16 session at $76.94, up 2.39% versus the previous close (+1.79). The stock opened at $75.06 and traded between $74.91 and $77.00 during that session. Session trading volume was 186K shares. The volume-weighted average price (VWAP) is $76.49.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares has a market capitalization of $5.86 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. KNSA is listed on the XNAS exchange. The company employs approximately 366 people. The recorded listing date is 2018-05-24.
On this page you can find market KNSA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.